NUFYMCO
- Product NDC
- 70710-2172
- 11-digit product format
- 707102172
- Labeler code
- 70710
- Product ID
- 70710-2172_0165619b-c985-47a1-8204-2e88bc96ed49
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- ranibizumab-leyk
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVITREAL
- Labeler
- Zydus Pharmaceuticals USA Inc.
- Application
- BLA761473
- Marketing category
- BLA
- Marketing start
- 2026-06-11
- Substance
- RANIBIZUMAB
- Active strength
- .3 mg/.05mL
- Pharmacologic classes
- Vascular Endothelial Growth Factor Inhibitor [EPC], Vascular Endothelial Growth Factor Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2027-12-31
- Current FDA listing
- Yes
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
Additional Listing Data#
- Finished product
- Yes
- Brand name base
- NUFYMCO
- Listing expiration
- 2027-12-31
Active Ingredients#
Ingredient, Strength table| Ingredient | Strength |
|---|
| RANIBIZUMAB | .3 mg/.05mL |
Purple Book Biologic Products#
BLA, Proprietary name, Proper name table| BLA | Proprietary name | Proper name | License type | Status | Latest source |
|---|
| 761473 | Nufymco | ranibizumab-leyk | 351(k) Interchangeable | Rx | 2026-09-01 |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Sample | Exclude flag | Status |
|---|
| 70710-2172-1 | 70710217201 | 1 VIAL, GLASS in 1 CARTON (70710-2172-1) / .05 mL in 1 VIAL, GLASS | 2026-06-11 | No | No | Current |